BC

Bicara Therapeutics Inc. Common Stock

BCAX · Nasdaq

Bicara Therapeutics Inc. Common Stock (BCAX) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Bicara Therapeutics Inc. Common Stock in 2026. The next earnings report is expected on November 17, 2026.

Earnings calendar

Next earnings date

17 Nov 2026

In 90 days

EPS estimate

-0.85

Revenue estimate

0

Past earnings

11 Aug 2026
EPS actual
-0.82 (0.0%)
estimate -0.82
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
30 Mar 2026
EPS actual
-0.68 (-1.2%)
estimate -0.67
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
10 Nov 2025
EPS actual
-0.67 (-23.8%)
estimate -0.54
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

Bicara Therapeutics met consensus estimates in its latest quarter, with EPS of -$0.82 essentially matching the -$0.8198 estimate and revenue of $0 meeting expectations. In the prior quarter, EPS missed expectations while revenue met estimates.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-b) for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts. Bicara Therapeutics Inc. is a subsidiary of Biocon Limited.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
Nasdaq
CEO
Claire Mazumdar Clemon
Employees
55
IPO date
13 Sep 2024
ISIN
US0554771032
Website
bicara.com

Frequently asked questions

When does Bicara Therapeutics Inc. Common Stock (BCAX) next report earnings?

Bicara Therapeutics Inc. Common Stock (BCAX) is scheduled to report earnings on November 17, 2026.

What was Bicara Therapeutics Inc. Common Stock's most recent earnings date?

Bicara Therapeutics Inc. Common Stock (BCAX) last reported earnings on August 11, 2026.

Where is Bicara Therapeutics Inc. Common Stock stock listed?

Bicara Therapeutics Inc. Common Stock (BCAX) is listed on Nasdaq.